gpt-dict.com

Ginger for Migraine

Verdict: Promising for acute attacks, but evidence is thin

A handful of small trials suggest ginger may ease the pain of a migraine attack within about two hours, but the evidence is limited and no headache authority yet recommends it. Treat it as a low-risk add-on worth trying, not a proven substitute for migraine medication.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade rests on a small but consistent positive signal for acute relief. A 2021 meta-analysis pooling three randomized trials (PMID 33293189) found ginger raised the chance of being pain-free at two hours (RR 1.79) and lowered pain scores (MD -1.27). In a head-to-head trial, 250 mg of ginger powder matched 50 mg sumatriptan for cutting attack severity while causing fewer side effects (PMID 23657930), and a separate trial showed ginger added to an IV NSAID outperformed placebo (56.7% vs 33.3% pain-free at two hours; PMID 29768938).

Several weaknesses keep this at preliminary rather than solid. The whole body of evidence is just three to four single-center trials of 100 or fewer patients, all rated low quality, with inconsistent dosing. Most data cover stopping an attack in progress, not preventing migraines; one positive study combined ginger with feverfew and was industry-funded (PMID 21631494), so ginger's own effect cannot be isolated.

Independent authorities offer little backing, which caps the grade. Regulators such as the NHS, EFSA, and the WHO endorse ginger mainly for nausea, not migraine, and no approved health claim exists. Major clinics are lukewarm: Mayo does not address it, Cleveland Clinic deliberately leaves ginger off its evidence-backed headache list, and the American Headache Society does not include it. High-dose ginger may also add a mild bleeding risk for people on blood thinners.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.58
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
76%
Broadly consistent
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
L3 MechanismPlausibility
0.65
L2 PubMedPrimary literature
0.70
Against Mixed Supports
▸View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.58
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標，未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

The efficacy of ginger for the treatment of migraine: A meta-analysis of randomized controlled studies
PMID: 33293189 2021 統合分析
Finding: Pooling 3 RCTs, ginger increased pain-free status at 2 h (RR 1.79, 95% CI 1.04 to 3.09, p=0.04) and reduced pain score at 2 h (MD -1.27, 95% CI -1.46 to -1.07, p<0.00001); treatment response (RR 2.04, 95% CI 0.35 to 11.94) and adverse events (RR 0.80, 95% CI 0.46 to 1.41) were not significantly different. Authors conclude ginger is safe and effective for migraine pain at 2 h.
🟠 Limited quality Effect size: RR pain-free 1.79; MD pain score -1.27
View on PubMed
Comparison Between the Efficacy of Ginger and Sumatriptan in the Ablative Treatment of the Common Migraine
PMID: 23657930 2014 RCT (double-blind) n = 100
Finding: Both treatments significantly reduced mean migraine severity within 2 h with no significant difference (ginger -4.6 units vs sumatriptan -4.7 units); 90%-or-better symptom reduction reached in 64% of ginger vs 70% of sumatriptan patients (NS). Adverse events were lower with ginger (4%, dyspepsia) than sumatriptan (20%).
🟠 Limited quality Effect size: Severity reduction ginger -4.6 vs sumatriptan -4.7 units (NS)
View on PubMed
Double-blind placebo-controlled randomized clinical trial of ginger (Zingiber officinale Rosc.) addition in migraine acute treatment
PMID: 29768938 2019 RCT (double-blind) n = 60
Finding: Ginger add-on to ketoprofen significantly improved response at 1 h (p=0.04), 1.5 h (p=0.01) and 2 h (p=0.04); pain-free at 2 h reached 56.7% with ginger vs 33.3% with placebo (p=0.03). Functional capacity and treatment satisfaction also favored ginger.
🟠 Limited quality Government Effect size: Pain-free at 2 h 56.7% vs 33.3% placebo (p=0.03)
View on PubMed
A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic M) in the treatment of migraine
PMID: 21631494 2011 隨機對照試驗 n = 60
Finding: Across 221 treated attacks, 32% of active vs 16% of placebo were pain-free at 2 h, and 63% of active vs 39% of placebo reported pain relief. Ginger was combined with feverfew, so the ginger-specific contribution cannot be isolated.
🟠 Limited quality ⚠️ Industry-funded Effect size: Pain-free at 2 h 32% vs 16% placebo (combination product)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
L4b EU EFSA
Neutral
no concerns for consumers were identified following the use of the additives up to the highest safe level in animal nutrition source↗
L4c UK NHS
Supportive
There are foods and drinks containing ginger which might help you feel less sick. Check with your pharmacist before taking ginger supplements during pregnancy. source↗
L4d TW TFDA / 衛福部
Supportive
中藥材係乾品，如為新鮮產品屬農產品，並不以中藥材管理 source↗
L4e WHO
Neutral
Rhizoma Zingiberis source↗
L5a NIH Office of Dietary Supplements
Cautious
L5c Cleveland Clinic
Neutral
L5d Harvard Health
Neutral
L5e Specialty Society (condition-mapped)
Not addressed
✓PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-migraine-INT-ginger-001 繁體中文版 →